ALMS Alumis Inc.

$ALMS got you 30%, saved you 26%, now back in. Everytime i leave a board, stock craters. When i visit the board, I bring profits. Welcome me with open arms.

$ALMS I do not undersatnd why the market thinks ALMS is pricing as a nothing company. the failed Lupus trial is the second indication. the first indication is plaque psoriasis, which is a success in 3 phase 3 trials and 2 phase 2 trials. this is almost guaranteed an approval, with annual peak sales much larger than the current market cap. People are thinking they have a failed drug. it is not true. they have a successful drug, and this drug failed for a secondary indication. it may not be the big one-pill platform for multiple indications as the company wanted, but it is still a successful drug.

$ALMS I bought 909 at $11.00 and 1020 at $9.80. Will continue to buy an additional $10,000 for every $1.00 drop. No debt, 92% institutional ownership, and small short interest. I agree with Oppenheimer on this one. It will bounce back: "Alumis' Share Price Fall After Envudeucitinib Trial Data Likely Overreaction, Oppenheimer Says"

$ALMS ⏳🧠👈🏻🧘🏻 .. envudeucitinib has already demonstrated strong efficacy, and in the long-term ONWARD3 study, 54% of patients achieved PASI 100 after 48 weeks. ⬇️⬇️⬇️

$ALMS the simplest explanation for why the stock would continue dropping so much after the large insider purchase is that it means there’s likely no major news - such as an acquisition - currently in the works, even though it is obviously bullish longer term by showing major confidence in the company’s prospects. So the short term speculators have been exiting at these ridiculous rock bottom prices even while it’s clearly oversold. I think large investors will be accumulating at these levels when they see that selling is finally over and this can rocket higher again after the short term specs have all exited at a loss.

$ALMS The Positive Impact: Higher Interest IncomeBecause Alumis does not have any debt to service, they completely bypass the primary risk of a rate hike (rising interest expenses). Instead, they benefit on the asset side of their balance sheet:

$ALMS stock is doing exactly what it should...there are major lines of resistance around 12 and 13, and a big gap fill around 15. We tested 12 and bounced a bit, we will try again today. It may take a little while, but I don't see how we won't try for 15. Certainly the value is there, the market just needs to do more digesting. I am not sure I would sell at 15, because 20 is a huge magnet as well. I can see this settling in the $20 zone, they sell off was way overdone vs the actual impact of the news and there is so much intrinsic value in the company.

$ALMS cannot believe Otezla generates roughly $2.1 billion to $2.3 billion in annual revenue for Amgen. According to Amgen’s official financial reports, its recent full-year global sales figures are: • 2025: $2.27 billion (a 7% increase year-over-year) • 2024: $2.10 billion. why ALMS is not worth anything? weird

$ALMS I thought about it - the only possible reason that the stock is dropping like this, could be that they actually over spent their cash, and they need to seek funding soon. with their cash level, they could not afford to fund the commercial of psoriasis drug alone. and they could not fund the phase 3 lupus subpopulation patients. so the potential buyers or partners are squeezing them with tough negotiations. next earnings we may see how much cash they actually have left.

$ALMS Promising and reassuring presentation at Morgan Stanley 24th Annual Healthcare Conference plus insiders buying up shares… Buying the turnaround!! Bullish with a conservative PT of $15 by end of Sept!

$ALMS 10 usd for 2 block buster drugs coming up and 500 mill in cash + 4b value in 3 months. Omg

$ALMS all the post lupus trial news shorts will be underwater after a break and hold above the 9/1 premarket high of 11.56, with no significant technical resistance till the 15-18 range. Should slice through like a hot knife through butter. 🚀🚀🚀 Also no weekly options so no OpEx till 9/18, so there won’t be the usual incentive for MMs to do their typical Friday price pinning action either. Looks like clear skies to the northeast. GL bulls ✈️ ✈️ ✈️

$ALMS macro events pulling whole biotech sector, except a few names, down- the war, gas prices, the hornet’s nest this current president has stirred up creates buying or shorting opportunities/ sucks for small biotechs trying to bring much needed drugs and services to the market. Hopefully 2028 US elections give American voters more stable, thoughtful, experienced candidates to choose from- the choices in 2024 were both bad- the one that seemed the better choice turned out to be all about war, personal enrichment, insider trading and price inflation- oh well. Hopefully this company does well longer term…

$ALMS Alumis Psoriasis drug in exp. sales a year: 5m users×100usd per month×12 =6 Billion USD(USA). My gut tells me that 'Lupus' Will 100% be the nr1 choice in the hospitals. With est. sales around 10b usd a year. Lupus will be the ult.choice for all types of cancer. 350-450 usd stock just sitting here to be bought, and zero % chance for dilution. 100 million shares outstanding, and thats it. Nobel price to the Alumis team? Screenshot this post and thank me one day. +5000%-9000% from current SP. How could I possible be knowing this? Its the cleansing cure for cancer. This will in time go up to 800 usd a share, and thats under just one week. This is a HKD type of stock, but with real value this time.

$ALMS oh dang fam, another 20%+ 🚀 ripper within hours memorialized into the stocktits records. Simons successor when are you ever gonna call me bro?

$ALMS boy that is one ugly chart. I don't quite understand why the stock is behaving this way, the bad news was way overdone. I have seen stocks like this stay at the lows, even make new lows, for a very long time and never recover. This seems to be the case here.

$ALMS New to this ticker guys, why did it drop 57%? Was there more nuance to missing the target? Appreciate any input.

Another strong week for the SST system! 🔥 💰 Total Profit: +$5,990 📈 Weekly Return: +5.99% 🎯 Win Rate: 78.95% 📊 19 Trades | 15 Winners | 4 Losers TOP TRADES $ALMS +11.9% and $SMMT +9.1% Consistent execution. Strong risk management. Let the system do the work. 🐂 SST — Trade Smart. Trade Consistent.

$ALMS ALMS Downgraded by Guggenheim -- Rating Changed to Neutral Author's Avatar GuruFocus News 09/03/2026 16:03

$ALMS sitting at an interesting spot here. Risk/reward looks tempting on paper but is the setup actually there or are we just hoping? Volume tells a story, price action tells another. Anyone actually confident in this one or just along for the ride?